MedPath
FDA Approval

Dexlansoprazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 3, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Dexlansoprazole(60 mg in 1 1)

Manufacturing Establishments8

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Abbvie Inc

TWI PHARMACEUTICALS, INC.

078458370

Anderson Brecon Inc

TWI PHARMACEUTICALS, INC.

053217022

Catalent Pharma Solutions, LLC

TWI PHARMACEUTICALS, INC.

014167995

Takeda GmbH

TWI PHARMACEUTICALS, INC.

313270015

Takeda Ireland Limited

TWI PHARMACEUTICALS, INC.

988980314

Patheon Manufacturing Services LLC

TWI PHARMACEUTICALS, INC.

079415560

F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.

TWI PHARMACEUTICALS, INC.

431189117

Takeda Pharmaceutical Company Limited

TWI PHARMACEUTICALS, INC.

695132431

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexlansoprazole delayed release

Product Details

NDC Product Code
24979-704
Application Number
NDA022287
Marketing Category
NDA authorized generic (C73605)
Route of Administration
ORAL
Effective Date
July 31, 2023
Code: UYE4T5I70XClass: ACTIBQuantity: 60 mg in 1 1
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)Inactive
Code: 74G4R6TH13Class: IACT
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2)Inactive
Code: 5KY68S2577Class: IACT
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMERInactive
Code: NX76LV5T8JClass: IACT
magnesium carbonateInactive
Code: 0E53J927NAClass: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14Class: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
sucroseInactive
Code: C151H8M554Class: IACT
talcInactive
Code: 7SEV7J4R1UClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
polyethylene glycol 8000Inactive
Code: Q662QK8M3BClass: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
triethyl citrateInactive
Code: 8Z96QXD6UMClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
carrageenanInactive
Code: 5C69YCD2YJClass: IACT
potassium chlorideInactive
Code: 660YQ98I10Class: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
FD&C Blue No. 2Inactive
Code: L06K8R7DQKClass: IACT

Dexlansoprazole delayed release

Product Details

NDC Product Code
24979-703
Application Number
NDA022287
Marketing Category
NDA authorized generic (C73605)
Route of Administration
ORAL
Effective Date
July 31, 2023
Code: UYE4T5I70XClass: ACTIBQuantity: 30 mg in 1 1
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)Inactive
Code: 74G4R6TH13Class: IACT
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMERInactive
Code: NX76LV5T8JClass: IACT
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:2)Inactive
Code: 5KY68S2577Class: IACT
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 2165RE0K14Class: IACT
sucroseInactive
Code: C151H8M554Class: IACT
magnesium carbonateInactive
Code: 0E53J927NAClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
talcInactive
Code: 7SEV7J4R1UClass: IACT
polyethylene glycol 8000Inactive
Code: Q662QK8M3BClass: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671PClass: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
triethyl citrateInactive
Code: 8Z96QXD6UMClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
carrageenanInactive
Code: 5C69YCD2YJClass: IACT
potassium chlorideInactive
Code: 660YQ98I10Class: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
FD&C Blue No. 2Inactive
Code: L06K8R7DQKClass: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933Class: IACT
© Copyright 2025. All Rights Reserved by MedPath